The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ignatieva V.I.

National Center for Technology Assessment in Healthcare;
National Medical Research Center for Therapy and Preventive Medicine;
Russian Medical Academy of Continuous Professional Education

Zyryanov S.K.

Peoples’ Friendship University of Russia;
Moscow City Clinical Hospital No. 24

Laktionov K.K.

Blokhin National Cancer Research Center;
Pirogov Russian National Research Medical University

Derkach E.V.

National Center for Technology Assessment in Healthcare

Yagnenkova E.E.

National Center for Technology Assessment in Healthcare

Drug therapy for locally advanced and metastatic non-small cell lung cancer with MET mutation: indirect comparison

Authors:

Ignatieva V.I., Zyryanov S.K., Laktionov K.K., Derkach E.V., Yagnenkova E.E.

More about the authors

Views: 345

Downloaded: 2


To cite this article:

Ignatieva VI, Zyryanov SK, Laktionov KK, Derkach EV, Yagnenkova EE. Drug therapy for locally advanced and metastatic non-small cell lung cancer with MET mutation: indirect comparison. Medical Technologies. Assessment and Choice. 2024;(3):82‑92. (In Russ.)
https://doi.org/10.17116/medtech20244603182

Recommended articles:

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.